The Research Team at The Queen Elizabeth Hospital in King’s Lynn has received £20,000 funding following its success in conducting clinical trials.
The Department of Health and Social Care (DHSC) has awarded the money after the Research and Development team surpassed the 500-patient target to participate in research for new treatments.
The ten-strong team has already played a role in the clinical trials for developing a number of new drugs, including Tolvaptan, which is used to treat polycystic kidney disease.
They have also been involved with testing a new device to check blood sugar levels for people with Type 1 Diabetes.
Over the course of the last year, the team has recruited more than 800 people to take part in trials.
Antonia Hardcastle, Research and Innovation Lead, said: “We are delighted to receive the money, it will help us grow the team so that we can offer patients better care and innovative treatments.”
“This money will enable us to pay for staff to continue the good work that we have already started.”
To download press release and photo, click here